| Login Register

Communication preferences

Cart

User logged in

Report adverse event

For Healthcare Professionals

Event Registration successful

You now have sucesfully register for the event and you can also access the latest updates, events and resources.

In case you would like to receive SMS-reminders for the event you have registered, please scroll down to provide your mobile number.

Account activated – pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

Event registration completed - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

Account activated - pending validation.

In the meantime, you can enjoy the public content on our website

Event Account activated - pending validation.

In the meantime, you can enjoy the public content on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

already registered

X »

Popup

Unit for Hours:H

Unit for Minutes: M

Filter redirection page URL: events.html

Filter Tags:Products

Filter Tags values when filtered by all Tags:All Products

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successfull

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successfull

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Tag Requirements value: all

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:$ciamTextareaNoCopyEmail

Patient profiles

Meet patients who may be suitable for the AREXVY vaccine.

IMAGE OF AN OLDER AFRICAN-AMERICAN FEMALE PATIENT

Eve, age 65

Medical history:

No underlying conditions
Has high blood pressure and high cholesterol

Lifestyle:

She eats a healthy diet to help manage her overall health
Stays active by playing with her grandchildren

Interaction with HCP:

Diligent about annual physicals and is proactive about her health, including keeping up to date on her vaccinations

Start the conversation about AREXVY because:

She is at risk of RSV disease due to her age and is eligible for vaccination.^1-3

Fictitious patient. May not be representative of the general population.

Darrell, age 69

Medical history:

Currently managing COPD

Lifestyle:

Lives a sedentary lifestyle and doesn’t prioritize exercise
Has gotten less mobile with age

Interaction with HCP:

Occasional visits with his respirologist for COPD checkups

Start the conversation about AREXVY because:

He is at risk of RSV disease due to his age and other risk factors, including COPD, and is eligible for vaccination.^1-3

Fictitious patient. May not be representative of the general population.

COPD = chronic obstructive pulmonary disease.

Kenzo, age 73

Medical history:

Type 2 diabetes

Lifestyle:

Enjoys travelling with his wife
Keeps his weight down and lives healthily

Interaction with HCP:

Goes to the doctor regularly to review his A1C levels

Start the conversation about AREXVY because:

He is at risk of RSV disease due to his age and other risk factors, including diabetes, and is eligible for vaccination.^1-4

Fictitious patient. May not be representative of the general population.

Leah, age 66

Medical history:

Currently managing chronic heart failure

Lifestyle:

Helps to care for her older parents
Often too busy to exercise or eat well

Interaction with HCP:

Doesn’t always prioritize her health and sometimes misses appointments

Start the conversation about AREXVY because:

She is at risk of RSV disease due to her age and other risk factors, including chronic heart failure, and is eligible for vaccination.^1-3

Fictitious patient. May not be representative of the general population.

Patient resources

Find additional AREXVY resources for your patients.

RESOURCES FOR YOUR PATIENTS

Recommendations

Review recommendations on RSV vaccination for adults aged ≥60 years.^4-7

LEARN MORE

See AREXVY efficacy data

Efficacy of AREXVY against RSV-associated LRTD in adults 60 years and older was evaluated in Study AReSVi-006.¹

LEARN MORE

References:

AREXVY Product Monograph, GlaxoSmithKline Inc.
Government of Canada. Respiratory syncytial virus (RSV): for health professionals. Available at: https://www.canada.ca/en/public-health/services/diseases/respiratory-syncytial-virus-rsv/health-professionals.html. Accessed February 10, 2023.
Centers for Disease Control and Prevention. Respiratory syncytial virus infection (RSV): for healthcare providers. Available at: https://www.cdc.gov/rsv/clinical/index.html. Accessed September 28, 2023.
Melgar M, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023. Morb Mortal Wkly Rep 2023;72:793–801.
Government of Canada. Respiratory syncytial virus (RSV): Canadian Immunization Guide. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/respiratory-syncytial-virus.html. Accessed January 26, 2024.
American Diabetes Association Professional Practice Committee. 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes – 2024. Diabetes Care 2024:47(Suppl.1):S52–76.
Global Initiative for Chronic Obstructive Lung Disease 2024 Report. Available at: https://goldcopd.org/wp-content/uploads/2024/01/GOLD-2024_v1.2-11Jan24_WMV-1.pdf. Accessed February 8, 2024.

Trademarks are owned by or licensed to the GSK group of companies.

104605 | 07/24

We use cookies

We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website, features and remember your preferences; advertising cookies help us share relevant content. Cookie Policy

Always active Strictly Necessary Cookies ❮

Necessary for the website to function appropriately, such as store session data during a website visit, to manage cookie and tag preferences, and to protect the security of the website. In addition some cookies are set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Performance cookies ❮

Enable the website to provide enhanced functionality and personalization, such as by helping us to measure how many visitors come to our websites, what sites our website visitors come from, and how often certain pages on our website are viewed. These cookies may be set by us or by third party providers, like our analytics service providers, whose services we have added to our pages. Please note that performance cookies include functional cookies. For more information on functional cookies, please refer to the Cookie Policy.
Advertising Cookies ❮

Allow us to target and re-target you with the relevant advertising. We and our advertising partners use information collected through these technologies to infer your interests in order to serve you more relevant advertisements on other sites. If you don’t allow these cookies, you will receive advertising, but it may be less relevant to you.

You are now leaving GSK’s website

Patient profiles

Patient resources

Find additional AREXVY resources for your patients.

RESOURCES FOR YOUR PATIENTS

Sorry, this site is not supported on Android v4.3 and below.

You are now leaving AREXVYhcp.ca

Patient profiles

Patient resources Find additional AREXVY resources for your patients.

RESOURCES FOR YOUR PATIENTS

Patient resources

Find additional AREXVY resources for your patients.